Boston Common Asset Management, LLC Abbott Laboratories Transaction History

Boston Common Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$95.06 - $111.52 $13,023 - $15,278	137 Added 2.24%	6,259 $687,000
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $6,192 - $7,169	64 Added 1.06%	6,122 $592,000
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $52,157 - $63,042	511 Added 9.21%	6,058 $658,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $75,595 - $92,183	-663 Reduced 10.68%	5,547 $656,000
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $37,200 - $45,550	322 Added 5.47%	6,210 $873,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2,099 - $2,323	18 Added 0.31%	5,888 $696,000
Q2 2021 Aug 19, 2021	BUY	$105.79 - $124.53 $44,431 - $52,302	420 Added 7.71%	5,870 $680,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $5,224 - $6,155	48 Added 0.89%	5,450 $653,000
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $567,210 - $618,096	5,402 New	5,402 $591,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Common Asset Management, LLC with notifications on news.